5 Ankylosing Spondylitis Clinical Trials in Fresno, CA (2026)

Q: How do I join a clinical trial in Fresno?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fresno research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Fresno

NCT07165028Recruiting

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

The main purpose of the SYNERGY-OUTCOMES study is to find out whether retatrutide and tirzepatide can prevent major adverse liver outcomes (MALO) in people with high-risk metabolic dysfunction-associa...

Fresno, CAPHASE34,500 participantsEli Lilly and Company

View Study Details

NCT04202341Recruiting

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion C5 inhibitor therapi...

Fresno, CA500 participantsAlexion Pharmaceuticals, Inc.

View Study Details

NCT04821154Recruiting

Persona Revision Knee System Outcomes

The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. Thi...

Fresno, CA380 participantsZimmer Biomet

View Study Details

NCT06975865Recruiting

The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell Disease

This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential study (Part A), followed by an open-label LTE period (Part B) to investigate the efficacy, and saf...

Fresno, CAPHASE3192 participantsSanofi

View Study Details

NCT07009860Recruiting

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Plac...

Fresno, CAPHASE2100 participantsAltimmune, Inc.

View Study Details

About Ankylosing Spondylitis Clinical Trials in Fresno

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 5 ankylosing spondylitis clinical trials recruiting participants in Fresno, CA. These studies are seeking a combined 5,672 participants. Research is being sponsored by Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Zimmer Biomet and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Fresno — FAQ

Are there ankylosing spondylitis clinical trials in Fresno?

Yes, there are 5 ankylosing spondylitis clinical trials currently recruiting in Fresno, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fresno?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fresno research site will contact you about next steps.

Are clinical trials in Fresno free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fresno studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 5 active trials in Fresno are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 19, 2026 from ClinicalTrials.gov